CStone to Begin Australian Trials of Solid Tumor Cancer Drug

CStone to Begin Australian Trials of Solid Tumor Cancer Drug

Suzhou’s CStone Pharma has been approved to start an Australian Phase I clinical trial of its CDK4/6 inhibitor as a treatment for solid tumor cancers. CS3002 is a selective inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6), a...

Read more
Luye Pharma Approved to Start Japan Trials of Novel Anti-depressant

Luye Pharma Approved to Start Japan Trials of Novel Anti-depressant

Luye Pharma of Yantai has been approved to start Japan trials of its novel treatment for depression, a serotonin-norepinephrine-dopamine triple reuptake inhibitor (SNDRI) in extended release tablet form. Ansofaxine Hydrochloride ER Tablets...

Read more
US Medical Device Maker Thermo Fisher to Build New China Factory

US Medical Device Maker Thermo Fisher to Build New China Factory

American medical machinery firm Thermo Fisher Scientific has agreed to build a new factory in China’s Jiangsu province with a vision of long-term development in the country. The base, located in Suzhou High-Tech Zone, will make disposable...

Read more
Pfizer Investing $500 Million in North Carolina Gene Therapy Facility, Adding 300 Jobs

Pfizer Investing $500 Million in North Carolina Gene Therapy Facility, Adding 300 Jobs

Pfizer announced it is putting an additional $500 million into the construction of its gene therapy manufacturing site in Sanford, North Carolina. It is planned to support the company’s investment in gene therapy research and development, much...

Read more
Yaoyanshe Raises $42 Million for On-Line CRO/CMO Services

Yaoyanshe Raises $42 Million for On-Line CRO/CMO Services

Yaoyanshe, a Shanghai on-line AI-based CRO/CMO, raised $42 million in a C funding round led by Eastern Bell Capital and Sequoia China. Founded in 2015, Yaoyanshe offers Trial.Link, a repository of China clinical trial information that connects...

Read more
Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.

Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.

Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that a license agreement has been reached with Biotheus Inc. (“Biotheus”), a privately held Chinese company based in Zhuhai, Guangdong, China. Under the license...

Read more
China News Weekly 124 – China Unveils Reform to Help Firms Borrow More Cheaply

China News Weekly 124 – China Unveils Reform to Help Firms Borrow More Cheaply

Click here to find more details This is NAI’s new China News Weekly. We will be covering the latest Chinese foreign investment trends every week. To continue to receive our China News Weekly, please click the button below to subscribe.

Read more
China’s LHHC Signs Up Vancouver’s Enlighta to Market AI Early Test for Cancer

China’s LHHC Signs Up Vancouver’s Enlighta to Market AI Early Test for Cancer

LHHC Medical Technology, a China AI company, announced a global cooperation with Vancouver’s Enlighta to market LHHC’s early cancer detection test. The “No Cancer” technology combines LHHC’s AI data models and...

Read more
China Adds 148 New Drugs to Basic Insurance List

China Adds 148 New Drugs to Basic Insurance List

China has added 148 drugs to its list of medicines covered by basic medical insurance plans, the first update in two years. The additions were comprised of 47 western drugs and 101 TCM products, including medicines for cancers, rare diseases...

Read more
Shenzhen Xpect Vision Closes $14 Million Round for New Imaging Tech

Shenzhen Xpect Vision Closes $14 Million Round for New Imaging Tech

Shenzhen Xpect Vision Technology closed a $14 million B financing to support development of its new imaging technologies. Founded in 2015, Xpect considers itself a leader in photon-counting X-ray imaging along with other new technologies such as...

Read more
CMS Acquires China Rights to Seven Generic Drugs from India’s Sun Pharma

CMS Acquires China Rights to Seven Generic Drugs from India’s Sun Pharma

Shenzhen’s China Medical System acquired China rights to seven generic drugs from India’s Sun Pharma. The seven drugs were not identified, but Sun Pharma said they have China market revenues of $1 billion annually. Two months ago, CMS...

Read more
India’s Natco Joins the March to China’s Market by Indian Pharmas

India’s Natco Joins the March to China’s Market by Indian Pharmas

India’s Natco Pharma, a company that specializes in complex generics, plans to build up its business in China, taking advantage of China’s speeded-up approval process to register products that are already approved elsewhere. Natco has...

Read more
Do NOT follow this link or you will be banned from the site!